Group 1 - Fund advisors are adopting a cautious investment approach in Q4, reducing allocations to active equity funds while increasing investments in index-enhanced products and sectors that hedge against volatility, such as non-ferrous metals and non-bank financials [1] - In October, the equity fund index fell by 2.21%, and the ordinary stock fund index decreased by 2.04%, indicating a challenging investment environment [1] - The overall allocation to the pharmaceutical and biological industry decreased, while the non-ferrous metals and non-bank financial sectors saw the highest increases in allocation by 0.52 and 0.39 percentage points, respectively [1] Group 2 - Non-bank financials are viewed as a sector that shares market beta, with recent market sentiment stabilizing, presenting potential trading opportunities [2] - After a rapid decline, gold has regained some interest from fund advisors, with specific funds increasing their positions in gold ETFs [2] - The new tax regulations on gold trading have introduced additional costs for physical gold delivery, impacting consumer prices, but have not significantly affected financial market transactions like gold ETFs [2]

Core Viewpoint - The article highlights a shift in investment strategies among fund advisory products, with a notable increase in allocations towards high-dividend and technology assets, while reducing exposure to consumer sectors [1][7][11]. Group 1: Fund Advisory Product Adjustments - In July, a total of 141 fund advisory products made adjustments, including 27 mixed equity and bond products and 64 equity products [1][6]. - Mixed equity and bond products increased their holdings in active equity funds while reducing allocations to index funds [1][6]. - Equity advisory products decreased their holdings in bond-oriented funds and increased their allocations to equity funds [1][6]. Group 2: Sector Allocation Changes - Fund advisory products overall reduced exposure to consumer sectors and increased allocations to pharmaceuticals, cyclical sectors, and technology [1][7]. - The highest increase in allocation was seen in the pharmaceutical and biotechnology sector (+0.47%) and non-ferrous metals (+0.31%), while the largest reductions were in food and beverage (-0.35%) and electronics (-0.23%) [7]. Group 3: Performance of Fund Products - Some equity advisory combinations have achieved over 20% excess returns this year, with specific products like Huabao Securities' Value Investment Fund V and Guolian Securities' Anxin Aggressive 90 showing returns of 30.88% and 25.59% respectively [9][10]. - Mixed equity and bond products with a higher proportion of equity funds also performed well, with returns of 14.72% and 12.92% for specific products [10]. Group 4: Market Outlook and Investment Strategies - Some advisory institutions maintain a relatively positive outlook on the market, citing improved funding conditions and potential inflows of external capital [11]. - Recommended investment directions include high-dividend stocks and technology assets, particularly in AI applications and semiconductors [11][12]. - The strategy of diversifying investments across different asset classes and markets is emphasized, suggesting a balanced approach to mitigate risks [12].